All Updates

All Updates

icon
Filter
Regulation/policy
PoLoPo submits application for USDA approval of its SuperAA platform
Plant-based Dairy & Egg
May 22, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Plant-based Dairy & Egg

Plant-based Dairy & Egg

May 22, 2024

PoLoPo submits application for USDA approval of its SuperAA platform

Regulation/policy

  • Israeli company PoLoPo, specializing in molecular farming, has applied for a Regulatory Status Review (RSR) from the US Department of Agriculture's Animal and Plant Health Inspection Service for its SuperAA platform.

  • The SuperAA platform is a proprietary system that uses metabolic engineering techniques to turn potatoes into miniature biofactories to create alternative proteins. The proteins are then extracted and dry-processed into a powder compatible with existing food production lines. The final protein powder is classified as non-GMO despite the initial genetic engineering.

  • Analyst QuickTake: The company unveiled the SuperAA platform in March 2024 to develop ovalbumin and patanin for various food tech applications, including plant-based eggs and dairy alternatives. This unveiling followed the company’s USD 1.75 million pre-seed funding round held in March 2023.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.